Barts & The London NHS Trust
Also known as: Barts and the London School of Medicine and Dentistry | Barts Charity | Barts Health NHS Trust | Barts Health NHS Trust, London, United Kingdom (NSMP-ORANGE trial) | Barts Health NHS Trust; Queen Mary University London | Barts Heart Centre | Barts & The London NHS Trust | Centre for Experimental Cancer Medicine (CECM), Barts Cancer Institute | Centre for Health Sciences, Barts and The London, QMUL | Centre for Health Sciences, Queen Mary's School of Medicine and Dentistry | Department ofRespiratory Medicine, London Chest Hospital, Barts& The London NHS Trust,Bonner Road, E2 9JX, London (UK) | Homerton University Hospital | Pain and Anaesthesia Research Centre, Barts Health NHS Trust | Queen Mary's School of Medicine & Dentistry, London (UK) | Queen Mary's School of Medicine & Dentistry, London, UK | Southampton NCRI/CR UK Experimental Cancer Medicines Centre | St. Bartholomew's Hospital | St Bartholomew's Hospital, London, UK | Translational Medicine & Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2012Last known activity
Sep 19, 2023
Timeline
2010s
- Apr 1, 2012
Barts & The London NHS Trust— Founded
Drugs by trial phase (96 distinct, 67 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (33 own, 0 via acquisition)
Phase 2 (34 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
- ACTH-Secreting Pituitary Adenoma
- Acute Coronary Syndrome
- Acute Kidney Injury
- Adenocarcinoma
- Anemia
- Angioedema
- Angioedemas, Hereditary
- Antiphospholipid Syndrome
- Arrhythmias, Cardiac
- Asthma
- Breast Neoplasms
- Carcinoma, Renal Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Chronic Disease
- Colorectal Neoplasms
- Communicable Diseases
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Drug-Related Side Effects and Adverse Reactions
- Headache
- Heart Failure
- Hematologic Neoplasms
- Hemorrhage
- Hyperalgesia
- Infarction
- Infections
- Influenza, Human
- Irritable Bowel Syndrome
- Ischemia
- Kidney Diseases
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Mesothelioma
- Migraine Disorders
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Plasma Cell
- Neuralgia
- Pituitary ACTH Hypersecretion
- Plasmacytoma
- Precancerous Conditions
- Preleukemia
- Prostatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency, Chronic
- Reperfusion Injury
- Respiratory Tract Infections
- Seminoma
- Small Cell Lung Carcinoma
- Syndrome
- Thromboembolism
- Triple Negative Breast Neoplasms
- Tuberculosis
- Tuberculosis, Pulmonary
- Uterine Cervical Neoplasms
- Venous Thromboembolism
- Vitamin D Deficiency
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT05874804Overall official - principal investigatorN/ASep 19, 2023
- NCT05711849Lead sponsorPhase 2Sep 1, 2023
- NCT05711849Overall official - principal investigatorPhase 2Sep 1, 2023
- NCT05418010CollaboratorPhase 2Nov 30, 2022
- NCT05255653Overall official - principal investigatorPhase 2/Phase 3Nov 11, 2021
- NCT05255653OfficialPhase 2/Phase 3Nov 11, 2021
- NCT04983979Lead sponsorPhase 2Aug 15, 2021
- NCT04973982Lead sponsorN/AAug 1, 2021
- NCT04579640CollaboratorPhase 3Oct 27, 2020
- NCT04579640CollaboratorPhase 3Oct 27, 2020
- NCT04604535CollaboratorN/AOct 22, 2020
- NCT04625608CollaboratorPhase 4Oct 6, 2020
- NCT04516759Overall official - principal investigatorPhase 2Aug 12, 2020
- NCT05216172Overall official - principal investigatorPhase 2Jan 21, 2020
- NCT04053816Lead sponsorPhase 3Oct 31, 2019
Details
- Founded
- London, GB Apr 1, 2012
- Last known activity
- Sep 19, 2023